Decorin suppresses stemness and migration potential of malignant peripheral nerve sheath tumor through inhibiting epidermal growth factor receptor signaling
Cancer stem cells (CSCs) play pivotal roles in the growth, invasion, metastasis, chemo-resistance in malignant peripheral nerve sheath tumor (MPNST). The current characterization of CSCs in MPNST is not complete. Decorin is a critical regulator of microenvironment, but its expression and function in...
Saved in:
Published in | Biochimica et biophysica acta. Molecular basis of disease Vol. 1870; no. 5; p. 167181 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier B.V
01.06.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Cancer stem cells (CSCs) play pivotal roles in the growth, invasion, metastasis, chemo-resistance in malignant peripheral nerve sheath tumor (MPNST). The current characterization of CSCs in MPNST is not complete. Decorin is a critical regulator of microenvironment, but its expression and function in CSCs of MPNST has not been studied. In the current study, Decorin levels and its relationship with lung and liver metastasis were determined in clinical specimens. Decorin expression in CD133-positive or CD44-positive CSCs was analyzed by RT-qPCR on cytospun MPNST cells after flow cytometry-based cell sorting. Decorin-positive cells were separated from Decorin-negative cells in transfected MPNST cell lines using a designed plasmid expressing red fluorescent protein (RFP) under a Decorin promoter. Tumor sphere formation, tumor growth, cell invasion, cell migration, and the resistance to chemotherapy-induced apoptosis were determined on Decorin-positive versus Decorin-negative MPNST cells. In vivo tumor growth was analyzed in mice receiving subcutaneous transplantation of Decorin-positive versus Decorin-negative MPNSTs. We found that Decorin levels were significantly downregulated in MPNST specimens, compared to non-tumorous adjacent tissue. Significantly lower Decorin levels were detected in MPNSTs with lung or liver metastasis compared to those without. Poorer patient survival was detected in Decorin-low MPNST, compared to Decorin-high subjects. More Decorin-negative cells were detected in CD133-positive MPNST cells than CD133-negative MPNST cells, and in CD44-positive MPNST cells than in CD44-negative MPNST cells. Compared to Decorin-positive MPNST cells, Decorin-negative MPNST cells generated significantly more tumor spheres in culture, were more invasive and migratory, and were more resistant to chemotherapy-induced apoptosis, likely due to the inhibition of epidermal growth factor receptor signaling by Decorin. Decorin-negative MPNST cells grew significantly larger tumor in vivo. Thus, depletion of Decorin may occur in CSCs in MPNSTs, serving possibly as a new therapeutic target.
[Display omitted]
•Decorin is reduced expression in malignant MPNSTs, particularly in those with lung or liver metastasis.•Lower Decorin levels correlate with poorer patient survival.•Loss of Decorin was observed in CSCs of MPNSTs.•Loss of Decorin likely regulate stemness of CSCs of MPNST cells through EGFR signaling. |
---|---|
AbstractList | Cancer stem cells (CSCs) play pivotal roles in the growth, invasion, metastasis, chemo-resistance in malignant peripheral nerve sheath tumor (MPNST). The current characterization of CSCs in MPNST is not complete. Decorin is a critical regulator of microenvironment, but its expression and function in CSCs of MPNST has not been studied. In the current study, Decorin levels and its relationship with lung and liver metastasis were determined in clinical specimens. Decorin expression in CD133-positive or CD44-positive CSCs was analyzed by RT-qPCR on cytospun MPNST cells after flow cytometry-based cell sorting. Decorin-positive cells were separated from Decorin-negative cells in transfected MPNST cell lines using a designed plasmid expressing red fluorescent protein (RFP) under a Decorin promoter. Tumor sphere formation, tumor growth, cell invasion, cell migration, and the resistance to chemotherapy-induced apoptosis were determined on Decorin-positive versus Decorin-negative MPNST cells. In vivo tumor growth was analyzed in mice receiving subcutaneous transplantation of Decorin-positive versus Decorin-negative MPNSTs. We found that Decorin levels were significantly downregulated in MPNST specimens, compared to non-tumorous adjacent tissue. Significantly lower Decorin levels were detected in MPNSTs with lung or liver metastasis compared to those without. Poorer patient survival was detected in Decorin-low MPNST, compared to Decorin-high subjects. More Decorin-negative cells were detected in CD133-positive MPNST cells than CD133-negative MPNST cells, and in CD44-positive MPNST cells than in CD44-negative MPNST cells. Compared to Decorin-positive MPNST cells, Decorin-negative MPNST cells generated significantly more tumor spheres in culture, were more invasive and migratory, and were more resistant to chemotherapy-induced apoptosis, likely due to the inhibition of epidermal growth factor receptor signaling by Decorin. Decorin-negative MPNST cells grew significantly larger tumor in vivo. Thus, depletion of Decorin may occur in CSCs in MPNSTs, serving possibly as a new therapeutic target. Cancer stem cells (CSCs) play pivotal roles in the growth, invasion, metastasis, chemo-resistance in malignant peripheral nerve sheath tumor (MPNST). The current characterization of CSCs in MPNST is not complete. Decorin is a critical regulator of microenvironment, but its expression and function in CSCs of MPNST has not been studied. In the current study, Decorin levels and its relationship with lung and liver metastasis were determined in clinical specimens. Decorin expression in CD133-positive or CD44-positive CSCs was analyzed by RT-qPCR on cytospun MPNST cells after flow cytometry-based cell sorting. Decorin-positive cells were separated from Decorin-negative cells in transfected MPNST cell lines using a designed plasmid expressing red fluorescent protein (RFP) under a Decorin promoter. Tumor sphere formation, tumor growth, cell invasion, cell migration, and the resistance to chemotherapy-induced apoptosis were determined on Decorin-positive versus Decorin-negative MPNST cells. In vivo tumor growth was analyzed in mice receiving subcutaneous transplantation of Decorin-positive versus Decorin-negative MPNSTs. We found that Decorin levels were significantly downregulated in MPNST specimens, compared to non-tumorous adjacent tissue. Significantly lower Decorin levels were detected in MPNSTs with lung or liver metastasis compared to those without. Poorer patient survival was detected in Decorin-low MPNST, compared to Decorin-high subjects. More Decorin-negative cells were detected in CD133-positive MPNST cells than CD133-negative MPNST cells, and in CD44-positive MPNST cells than in CD44-negative MPNST cells. Compared to Decorin-positive MPNST cells, Decorin-negative MPNST cells generated significantly more tumor spheres in culture, were more invasive and migratory, and were more resistant to chemotherapy-induced apoptosis, likely due to the inhibition of epidermal growth factor receptor signaling by Decorin. Decorin-negative MPNST cells grew significantly larger tumor in vivo. Thus, depletion of Decorin may occur in CSCs in MPNSTs, serving possibly as a new therapeutic target. [Display omitted] •Decorin is reduced expression in malignant MPNSTs, particularly in those with lung or liver metastasis.•Lower Decorin levels correlate with poorer patient survival.•Loss of Decorin was observed in CSCs of MPNSTs.•Loss of Decorin likely regulate stemness of CSCs of MPNST cells through EGFR signaling. Cancer stem cells (CSCs) play pivotal roles in the growth, invasion, metastasis, chemo-resistance in malignant peripheral nerve sheath tumor (MPNST). The current characterization of CSCs in MPNST is not complete. Decorin is a critical regulator of microenvironment, but its expression and function in CSCs of MPNST has not been studied. In the current study, Decorin levels and its relationship with lung and liver metastasis were determined in clinical specimens. Decorin expression in CD133-positive or CD44-positive CSCs was analyzed by RT-qPCR on cytospun MPNST cells after flow cytometry-based cell sorting. Decorin-positive cells were separated from Decorin-negative cells in transfected MPNST cell lines using a designed plasmid expressing red fluorescent protein (RFP) under a Decorin promoter. Tumor sphere formation, tumor growth, cell invasion, cell migration, and the resistance to chemotherapy-induced apoptosis were determined on Decorin-positive versus Decorin-negative MPNST cells. In vivo tumor growth was analyzed in mice receiving subcutaneous transplantation of Decorin-positive versus Decorin-negative MPNSTs. We found that Decorin levels were significantly downregulated in MPNST specimens, compared to non-tumorous adjacent tissue. Significantly lower Decorin levels were detected in MPNSTs with lung or liver metastasis compared to those without. Poorer patient survival was detected in Decorin-low MPNST, compared to Decorin-high subjects. More Decorin-negative cells were detected in CD133-positive MPNST cells than CD133-negative MPNST cells, and in CD44-positive MPNST cells than in CD44-negative MPNST cells. Compared to Decorin-positive MPNST cells, Decorin-negative MPNST cells generated significantly more tumor spheres in culture, were more invasive and migratory, and were more resistant to chemotherapy-induced apoptosis, likely due to the inhibition of epidermal growth factor receptor signaling by Decorin. Decorin-negative MPNST cells grew significantly larger tumor in vivo. Thus, depletion of Decorin may occur in CSCs in MPNSTs, serving possibly as a new therapeutic target.Cancer stem cells (CSCs) play pivotal roles in the growth, invasion, metastasis, chemo-resistance in malignant peripheral nerve sheath tumor (MPNST). The current characterization of CSCs in MPNST is not complete. Decorin is a critical regulator of microenvironment, but its expression and function in CSCs of MPNST has not been studied. In the current study, Decorin levels and its relationship with lung and liver metastasis were determined in clinical specimens. Decorin expression in CD133-positive or CD44-positive CSCs was analyzed by RT-qPCR on cytospun MPNST cells after flow cytometry-based cell sorting. Decorin-positive cells were separated from Decorin-negative cells in transfected MPNST cell lines using a designed plasmid expressing red fluorescent protein (RFP) under a Decorin promoter. Tumor sphere formation, tumor growth, cell invasion, cell migration, and the resistance to chemotherapy-induced apoptosis were determined on Decorin-positive versus Decorin-negative MPNST cells. In vivo tumor growth was analyzed in mice receiving subcutaneous transplantation of Decorin-positive versus Decorin-negative MPNSTs. We found that Decorin levels were significantly downregulated in MPNST specimens, compared to non-tumorous adjacent tissue. Significantly lower Decorin levels were detected in MPNSTs with lung or liver metastasis compared to those without. Poorer patient survival was detected in Decorin-low MPNST, compared to Decorin-high subjects. More Decorin-negative cells were detected in CD133-positive MPNST cells than CD133-negative MPNST cells, and in CD44-positive MPNST cells than in CD44-negative MPNST cells. Compared to Decorin-positive MPNST cells, Decorin-negative MPNST cells generated significantly more tumor spheres in culture, were more invasive and migratory, and were more resistant to chemotherapy-induced apoptosis, likely due to the inhibition of epidermal growth factor receptor signaling by Decorin. Decorin-negative MPNST cells grew significantly larger tumor in vivo. Thus, depletion of Decorin may occur in CSCs in MPNSTs, serving possibly as a new therapeutic target. |
ArticleNumber | 167181 |
Author | Yu, Cong Chen, Lin Jia, Xiaotian |
Author_xml | – sequence: 1 givenname: Xiaotian surname: Jia fullname: Jia, Xiaotian – sequence: 2 givenname: Lin surname: Chen fullname: Chen, Lin email: 447836459@qq.com – sequence: 3 givenname: Cong surname: Yu fullname: Yu, Cong email: drcongyu@yeah.net |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38653361$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkc1u1TAQhS1URG8Lb4CQl2xysWPHN2GBhEoLSJXYgMTO8s8k8VViB9sp6rvwsPiSdsMCZjOj0XfO4pwLdOaDB4ReUrKnhIo3x73Wyrq0r0nN91QcaEufoB1tD11VC_L9DO1IVzcV56w7RxcpHUkZcSDP0DlrRcOYoDv06wOYEJ3HaV2WCClBwinD7MuJlbd4dkNU2QWPl5DBZ6cmHHo8q8kNXvmMF4huGSGWv4d4BziNoPKI8zqHiPMYwzqM2PnRaZedHzAszkIsBniI4Wche2VyQSMYWE5HOjlPBX2OnvZqSvDiYV-ibzfXX68-VbdfPn6-en9bGSbqXGljetaYQy96WzyYBm14y1Vd17otT9KKrrGm65RVRNAGeKsaxqmlTNdCH9gler35LjH8WCFlObtkYJqUh7AmyQhvKO14Iwr66gFd9QxWLtHNKt7Lx0QL8HYDTAwpReilcflPgDkqN0lK5Kk-eZRbffJUn9zqK2L-l_jR_z-yd5sMSkh3DqJMxoE3YF0JNUsb3L8NfgPa3buV |
CitedBy_id | crossref_primary_10_1111_vco_13042 |
Cites_doi | 10.1038/s42003-020-01590-0 10.1093/carcin/bgr293 10.1002/cncr.33195 10.1016/j.matbio.2017.10.005 10.1371/journal.pone.0134111 10.18632/oncotarget.191 10.1186/1756-9966-29-6 10.18632/oncotarget.173 10.1152/ajpcell.00016.2022 10.1002/cbf.3445 10.3389/fonc.2021.801801 10.1038/sj.onc.1208329 10.1007/s10719-017-9780-9 10.1038/s41598-020-69787-1 10.1016/j.cca.2019.01.003 10.1158/1078-0432.CCR-21-1779 10.1002/mc.22427 10.1016/j.canlet.2008.10.015 10.1089/scd.2008.0338 10.2353/ajpath.2008.080275 10.1038/s41388-021-01773-x 10.1038/s41388-022-02290-1 10.3390/ijms241713596 10.2217/imt.14.108 10.1016/j.stem.2014.11.012 |
ContentType | Journal Article |
Copyright | 2024 Elsevier B.V. Copyright © 2024 Elsevier B.V. All rights reserved. |
Copyright_xml | – notice: 2024 Elsevier B.V. – notice: Copyright © 2024 Elsevier B.V. All rights reserved. |
DBID | 6I. AAFTH AAYXX CITATION NPM 7X8 |
DOI | 10.1016/j.bbadis.2024.167181 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry Biology |
EISSN | 1879-260X |
ExternalDocumentID | 38653361 10_1016_j_bbadis_2024_167181 S0925443924001704 |
Genre | Journal Article |
GroupedDBID | --- --K --M .~1 0R~ 1B1 1RT 1~. 1~5 23N 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 6I. 7-5 71M 8P~ 9JM AAEDT AAEDW AAFTH AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXUO AAYWO ABBQC ABEFU ABFNM ABGSF ABMAC ABMZM ABUDA ABWVN ABXDB ACDAQ ACIEU ACIUM ACRLP ACRPL ADBBV ADEZE ADMUD ADNMO ADUVX ADVLN AEBSH AEHWI AEIPS AEKER AEXQZ AFJKZ AFTJW AFXIZ AGCQF AGHFR AGQPQ AGRNS AGUBO AGYEJ AHHHB AIEXJ AIIUN AIKHN AITUG AJRQY ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 EBS EFJIC EJD EO8 EO9 EP2 EP3 FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HLW HVGLF HZ~ IHE IXB J1W KOM LX3 M41 MO0 N9A O-L O9- OAUVE OK1 OZT P-8 P-9 PC. Q38 R2- ROL RPZ SBG SDF SDG SDP SES SEW SPCBC SSH SSU SSZ T5K UQL WUQ XJT XPP ~G- AAYXX CITATION EFKBS NPM 7X8 |
ID | FETCH-LOGICAL-c362t-bccf35c7f6fdece3bebc484a222b8f6f08695dc99ada0615e48a5341d13b26b73 |
IEDL.DBID | IXB |
ISSN | 0925-4439 1879-260X |
IngestDate | Fri Jul 11 15:35:59 EDT 2025 Mon Jul 21 06:04:27 EDT 2025 Thu Jul 03 08:45:22 EDT 2025 Thu Apr 24 22:57:25 EDT 2025 Sat Jul 05 17:10:27 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | Malignant peripheral nerve sheath tumor (MPNST) Stemness Decorin Cancer stem cells (CSCs) Cancer metastasis |
Language | English |
License | This article is made available under the Elsevier license. Copyright © 2024 Elsevier B.V. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c362t-bccf35c7f6fdece3bebc484a222b8f6f08695dc99ada0615e48a5341d13b26b73 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S0925443924001704 |
PMID | 38653361 |
PQID | 3045119456 |
PQPubID | 23479 |
ParticipantIDs | proquest_miscellaneous_3045119456 pubmed_primary_38653361 crossref_citationtrail_10_1016_j_bbadis_2024_167181 crossref_primary_10_1016_j_bbadis_2024_167181 elsevier_sciencedirect_doi_10_1016_j_bbadis_2024_167181 |
PublicationCentury | 2000 |
PublicationDate | 2024-06-01 |
PublicationDateYYYYMMDD | 2024-06-01 |
PublicationDate_xml | – month: 06 year: 2024 text: 2024-06-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | Biochimica et biophysica acta. Molecular basis of disease |
PublicationTitleAlternate | Biochim Biophys Acta Mol Basis Dis |
PublicationYear | 2024 |
Publisher | Elsevier B.V |
Publisher_xml | – name: Elsevier B.V |
References | Diehl, Huber, Trebicka, Wygrecka, Iozzo, Schaefer (bb0030) 2021; 11 Kemper, Grandela, Medema (bb0045) 2010; 1 Buraschi, Neill, Iozzo (bb0035) 2019; 75-76 Gu, Zhang, Wu, Xu, Cui, Yang, Zhao, Sun (bb0085) 2010; 29 Farace, Oliver, Melguizo, Alvarez, Bandiera, Rama, Malaguarnera, Ortiz, Madeddu, Prados (bb0100) 2015; 10 Hu, Villodre, Larson, Rahal, Wang, Gong, Song, Krishnamurthy, Ueno, Tripathy, Woodward, Debeb (bb0070) 2021; 4 Bi, Xia, Fan, Mu, Zhang, Iozzo, Yang (bb0110) 2016; 55 Xie, Mondal, Ulas, Neill, Iozzo (bb0025) 2022; 322 Voigt, Quelle (bb0020) 2023; 24 Oldham, Berinstein, Medin (bb0130) 2015; 7 Curtin, Lorenzi (bb0040) 2010; 1 Goldoni, Seidler, Heath, Fassan, Baffa, Thakur, Owens, McQuillan, Iozzo (bb0075) 2008; 173 Mallard, Tiralongo (bb0055) 2017; 34 Appunni, Anand, Khandelwal, Gupta, Rubens, Sharma (bb0065) 2019; 491 Wu, Wu (bb0060) 2009; 18 Manji, Van Tine, Lee, Raufi, Pellicciotta, Hirbe, Pradhan, Chen, Rabadan, Schwartz (bb0010) 2021; 27 Thomson, Pundavela, Perrino, Coover, Choi, Chaney, Rizvi, Largaespada, Ratner (bb0120) 2021; 40 Vougiouklakis, Aung, Vasudevaraja, Prieto, Torres-Cabala, Sulman, Snuderl, Jour (bb0125) 2020; 10 Reed, Waterhouse, Kirby, Kay, Owens, McQuillan, Iozzo (bb0080) 2005; 24 Zeuner, Todaro, Stassi, De Maria (bb0050) 2014; 15 Salnikov, Kusumawidjaja, Rausch, Bruns, Gross, Khamidjanov, Ryschich, Gebhard, Moldenhauer, Buchler, Schemmer, Herr (bb0090) 2009; 275 Deng, Xue, Xu, Wang, Wei, Ke, Wang, Chen (bb0105) 2020; 38 Somatilaka, Sadek, McKay, Le (bb0005) 2022; 41 Bi, Pohl, Qian, Yang, Gou, Guzman, Kajdacsy-Balla, Iozzo, Yang (bb0115) 2012; 33 Abdou Hassan, Muqresh, Omer (bb0095) 2022; 14 Geller, Pressey, Smith, Kudgus, Cajaiba, Reid, Hall, Barkauskas, Voss, Cho, Berg, Dome, Fox, Weigel (bb0015) 2020; 126 Kemper (10.1016/j.bbadis.2024.167181_bb0045) 2010; 1 Salnikov (10.1016/j.bbadis.2024.167181_bb0090) 2009; 275 Buraschi (10.1016/j.bbadis.2024.167181_bb0035) 2019; 75-76 Xie (10.1016/j.bbadis.2024.167181_bb0025) 2022; 322 Voigt (10.1016/j.bbadis.2024.167181_bb0020) 2023; 24 Geller (10.1016/j.bbadis.2024.167181_bb0015) 2020; 126 Goldoni (10.1016/j.bbadis.2024.167181_bb0075) 2008; 173 Reed (10.1016/j.bbadis.2024.167181_bb0080) 2005; 24 Vougiouklakis (10.1016/j.bbadis.2024.167181_bb0125) 2020; 10 Manji (10.1016/j.bbadis.2024.167181_bb0010) 2021; 27 Oldham (10.1016/j.bbadis.2024.167181_bb0130) 2015; 7 Appunni (10.1016/j.bbadis.2024.167181_bb0065) 2019; 491 Curtin (10.1016/j.bbadis.2024.167181_bb0040) 2010; 1 Abdou Hassan (10.1016/j.bbadis.2024.167181_bb0095) 2022; 14 Deng (10.1016/j.bbadis.2024.167181_bb0105) 2020; 38 Somatilaka (10.1016/j.bbadis.2024.167181_bb0005) 2022; 41 Diehl (10.1016/j.bbadis.2024.167181_bb0030) 2021; 11 Gu (10.1016/j.bbadis.2024.167181_bb0085) 2010; 29 Wu (10.1016/j.bbadis.2024.167181_bb0060) 2009; 18 Mallard (10.1016/j.bbadis.2024.167181_bb0055) 2017; 34 Farace (10.1016/j.bbadis.2024.167181_bb0100) 2015; 10 Hu (10.1016/j.bbadis.2024.167181_bb0070) 2021; 4 Bi (10.1016/j.bbadis.2024.167181_bb0110) 2016; 55 Bi (10.1016/j.bbadis.2024.167181_bb0115) 2012; 33 Thomson (10.1016/j.bbadis.2024.167181_bb0120) 2021; 40 Zeuner (10.1016/j.bbadis.2024.167181_bb0050) 2014; 15 |
References_xml | – volume: 34 start-page: 441 year: 2017 end-page: 452 ident: bb0055 article-title: Cancer stem cell marker glycosylation: nature, function and significance publication-title: Glycoconj. J. – volume: 15 start-page: 692 year: 2014 end-page: 705 ident: bb0050 article-title: Colorectal cancer stem cells: from the crypt to the clinic publication-title: Cell Stem Cell – volume: 322 start-page: C554 year: 2022 end-page: C566 ident: bb0025 article-title: Oncosuppressive roles of decorin through regulation of multiple receptors and diverse signaling pathways publication-title: Am. J. Physiol. Cell Physiol. – volume: 29 start-page: 6 year: 2010 ident: bb0085 article-title: Differential expression of decorin, EGFR and cyclin D1 during mammary gland carcinogenesis in TA2 mice with spontaneous breast cancer publication-title: J. Exp. Clin. Cancer Res. – volume: 4 start-page: 72 year: 2021 ident: bb0070 article-title: Decorin-mediated suppression of tumorigenesis, invasion, and metastasis in inflammatory breast cancer publication-title: Commun. Biol. – volume: 173 start-page: 844 year: 2008 end-page: 855 ident: bb0075 article-title: An antimetastatic role for decorin in breast cancer publication-title: Am. J. Pathol. – volume: 10 year: 2020 ident: bb0125 article-title: Correlative study of epigenetic regulation of tumor microenvironment in spindle cell melanomas and cutaneous malignant peripheral nerve sheath tumors publication-title: Sci. Rep. – volume: 33 start-page: 326 year: 2012 end-page: 330 ident: bb0115 article-title: Decorin-mediated inhibition of colorectal cancer growth and migration is associated with E-cadherin in vitro and in mice publication-title: Carcinogenesis – volume: 27 start-page: 5519 year: 2021 end-page: 5527 ident: bb0010 article-title: A phase I study of the combination of Pexidartinib and Sirolimus to target tumor-associated macrophages in Unresectable sarcoma and malignant peripheral nerve sheath tumors publication-title: Clin. Cancer Res. – volume: 11 year: 2021 ident: bb0030 article-title: The role of Decorin and Biglycan signaling in tumorigenesis publication-title: Front. Oncol. – volume: 18 start-page: 1127 year: 2009 end-page: 1134 ident: bb0060 article-title: CD133 as a marker for cancer stem cells: progresses and concerns publication-title: Stem Cells Dev. – volume: 7 start-page: 271 year: 2015 end-page: 284 ident: bb0130 article-title: Lentiviral vectors in cancer immunotherapy publication-title: Immunotherapy – volume: 24 year: 2023 ident: bb0020 article-title: FOXM1, MEK, and CDK4/6: new targets for malignant peripheral nerve sheath tumor therapy publication-title: Int. J. Mol. Sci. – volume: 40 start-page: 4229 year: 2021 end-page: 4241 ident: bb0120 article-title: WNT5A inhibition alters the malignant peripheral nerve sheath tumor microenvironment and enhances tumor growth publication-title: Oncogene – volume: 10 year: 2015 ident: bb0100 article-title: Microenvironmental modulation of Decorin and Lumican in Temozolomide-resistant glioblastoma and neuroblastoma Cancer stem-like cells publication-title: PloS One – volume: 24 start-page: 1104 year: 2005 end-page: 1110 ident: bb0080 article-title: Decorin prevents metastatic spreading of breast cancer publication-title: Oncogene – volume: 55 start-page: 1786 year: 2016 end-page: 1795 ident: bb0110 article-title: Oncogenic activin C interacts with decorin in colorectal cancer in vivo and in vitro publication-title: Mol. Carcinog. – volume: 75-76 start-page: 260 year: 2019 end-page: 270 ident: bb0035 article-title: Decorin is a devouring proteoglycan: remodeling of intracellular catabolism via autophagy and mitophagy publication-title: Matrix Biol. – volume: 41 start-page: 2405 year: 2022 end-page: 2421 ident: bb0005 article-title: Malignant peripheral nerve sheath tumor: models, biology, and translation publication-title: Oncogene – volume: 14 year: 2022 ident: bb0095 article-title: The potential role of CD44 and CD133 in colorectal stem cell cancer publication-title: Cureus – volume: 275 start-page: 185 year: 2009 end-page: 193 ident: bb0090 article-title: Cancer stem cell marker expression in hepatocellular carcinoma and liver metastases is not sufficient as single prognostic parameter publication-title: Cancer Lett. – volume: 491 start-page: 1 year: 2019 end-page: 7 ident: bb0065 article-title: Small leucine rich proteoglycans (decorin, biglycan and lumican) in cancer publication-title: Clin. Chim. Acta – volume: 1 start-page: 387 year: 2010 end-page: 395 ident: bb0045 article-title: Molecular identification and targeting of colorectal cancer stem cells publication-title: Oncotarget – volume: 38 start-page: 47 year: 2020 end-page: 57 ident: bb0105 article-title: Chrysophanol exhibits inhibitory activities against colorectal cancer by targeting decorin publication-title: Cell Biochem. Funct. – volume: 126 start-page: 5303 year: 2020 end-page: 5310 ident: bb0015 article-title: ADVL1522: a phase 2 study of lorvotuzumab mertansine (IMGN901) in children with relapsed or refractory wilms tumor, rhabdomyosarcoma, neuroblastoma, pleuropulmonary blastoma, malignant peripheral nerve sheath tumor, or synovial sarcoma-a Children’s oncology group study publication-title: Cancer – volume: 1 start-page: 552 year: 2010 end-page: 566 ident: bb0040 article-title: Drug discovery approaches to target Wnt signaling in cancer stem cells publication-title: Oncotarget – volume: 4 start-page: 72 issue: 1 year: 2021 ident: 10.1016/j.bbadis.2024.167181_bb0070 article-title: Decorin-mediated suppression of tumorigenesis, invasion, and metastasis in inflammatory breast cancer publication-title: Commun. Biol. doi: 10.1038/s42003-020-01590-0 – volume: 33 start-page: 326 issue: 2 year: 2012 ident: 10.1016/j.bbadis.2024.167181_bb0115 article-title: Decorin-mediated inhibition of colorectal cancer growth and migration is associated with E-cadherin in vitro and in mice publication-title: Carcinogenesis doi: 10.1093/carcin/bgr293 – volume: 126 start-page: 5303 issue: 24 year: 2020 ident: 10.1016/j.bbadis.2024.167181_bb0015 publication-title: Cancer doi: 10.1002/cncr.33195 – volume: 75-76 start-page: 260 year: 2019 ident: 10.1016/j.bbadis.2024.167181_bb0035 article-title: Decorin is a devouring proteoglycan: remodeling of intracellular catabolism via autophagy and mitophagy publication-title: Matrix Biol. doi: 10.1016/j.matbio.2017.10.005 – volume: 10 issue: 7 year: 2015 ident: 10.1016/j.bbadis.2024.167181_bb0100 article-title: Microenvironmental modulation of Decorin and Lumican in Temozolomide-resistant glioblastoma and neuroblastoma Cancer stem-like cells publication-title: PloS One doi: 10.1371/journal.pone.0134111 – volume: 1 start-page: 552 issue: 7 year: 2010 ident: 10.1016/j.bbadis.2024.167181_bb0040 article-title: Drug discovery approaches to target Wnt signaling in cancer stem cells publication-title: Oncotarget doi: 10.18632/oncotarget.191 – volume: 29 start-page: 6 issue: 1 year: 2010 ident: 10.1016/j.bbadis.2024.167181_bb0085 article-title: Differential expression of decorin, EGFR and cyclin D1 during mammary gland carcinogenesis in TA2 mice with spontaneous breast cancer publication-title: J. Exp. Clin. Cancer Res. doi: 10.1186/1756-9966-29-6 – volume: 14 issue: 10 year: 2022 ident: 10.1016/j.bbadis.2024.167181_bb0095 article-title: The potential role of CD44 and CD133 in colorectal stem cell cancer publication-title: Cureus – volume: 1 start-page: 387 issue: 6 year: 2010 ident: 10.1016/j.bbadis.2024.167181_bb0045 article-title: Molecular identification and targeting of colorectal cancer stem cells publication-title: Oncotarget doi: 10.18632/oncotarget.173 – volume: 322 start-page: C554 issue: 3 year: 2022 ident: 10.1016/j.bbadis.2024.167181_bb0025 article-title: Oncosuppressive roles of decorin through regulation of multiple receptors and diverse signaling pathways publication-title: Am. J. Physiol. Cell Physiol. doi: 10.1152/ajpcell.00016.2022 – volume: 38 start-page: 47 issue: 1 year: 2020 ident: 10.1016/j.bbadis.2024.167181_bb0105 article-title: Chrysophanol exhibits inhibitory activities against colorectal cancer by targeting decorin publication-title: Cell Biochem. Funct. doi: 10.1002/cbf.3445 – volume: 11 year: 2021 ident: 10.1016/j.bbadis.2024.167181_bb0030 article-title: The role of Decorin and Biglycan signaling in tumorigenesis publication-title: Front. Oncol. doi: 10.3389/fonc.2021.801801 – volume: 24 start-page: 1104 issue: 6 year: 2005 ident: 10.1016/j.bbadis.2024.167181_bb0080 article-title: Decorin prevents metastatic spreading of breast cancer publication-title: Oncogene doi: 10.1038/sj.onc.1208329 – volume: 34 start-page: 441 issue: 4 year: 2017 ident: 10.1016/j.bbadis.2024.167181_bb0055 article-title: Cancer stem cell marker glycosylation: nature, function and significance publication-title: Glycoconj. J. doi: 10.1007/s10719-017-9780-9 – volume: 10 issue: 1 year: 2020 ident: 10.1016/j.bbadis.2024.167181_bb0125 article-title: Correlative study of epigenetic regulation of tumor microenvironment in spindle cell melanomas and cutaneous malignant peripheral nerve sheath tumors publication-title: Sci. Rep. doi: 10.1038/s41598-020-69787-1 – volume: 491 start-page: 1 year: 2019 ident: 10.1016/j.bbadis.2024.167181_bb0065 article-title: Small leucine rich proteoglycans (decorin, biglycan and lumican) in cancer publication-title: Clin. Chim. Acta doi: 10.1016/j.cca.2019.01.003 – volume: 27 start-page: 5519 issue: 20 year: 2021 ident: 10.1016/j.bbadis.2024.167181_bb0010 article-title: A phase I study of the combination of Pexidartinib and Sirolimus to target tumor-associated macrophages in Unresectable sarcoma and malignant peripheral nerve sheath tumors publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-21-1779 – volume: 55 start-page: 1786 issue: 11 year: 2016 ident: 10.1016/j.bbadis.2024.167181_bb0110 article-title: Oncogenic activin C interacts with decorin in colorectal cancer in vivo and in vitro publication-title: Mol. Carcinog. doi: 10.1002/mc.22427 – volume: 275 start-page: 185 issue: 2 year: 2009 ident: 10.1016/j.bbadis.2024.167181_bb0090 article-title: Cancer stem cell marker expression in hepatocellular carcinoma and liver metastases is not sufficient as single prognostic parameter publication-title: Cancer Lett. doi: 10.1016/j.canlet.2008.10.015 – volume: 18 start-page: 1127 issue: 8 year: 2009 ident: 10.1016/j.bbadis.2024.167181_bb0060 article-title: CD133 as a marker for cancer stem cells: progresses and concerns publication-title: Stem Cells Dev. doi: 10.1089/scd.2008.0338 – volume: 173 start-page: 844 issue: 3 year: 2008 ident: 10.1016/j.bbadis.2024.167181_bb0075 article-title: An antimetastatic role for decorin in breast cancer publication-title: Am. J. Pathol. doi: 10.2353/ajpath.2008.080275 – volume: 40 start-page: 4229 issue: 24 year: 2021 ident: 10.1016/j.bbadis.2024.167181_bb0120 article-title: WNT5A inhibition alters the malignant peripheral nerve sheath tumor microenvironment and enhances tumor growth publication-title: Oncogene doi: 10.1038/s41388-021-01773-x – volume: 41 start-page: 2405 issue: 17 year: 2022 ident: 10.1016/j.bbadis.2024.167181_bb0005 article-title: Malignant peripheral nerve sheath tumor: models, biology, and translation publication-title: Oncogene doi: 10.1038/s41388-022-02290-1 – volume: 24 issue: 17 year: 2023 ident: 10.1016/j.bbadis.2024.167181_bb0020 article-title: FOXM1, MEK, and CDK4/6: new targets for malignant peripheral nerve sheath tumor therapy publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms241713596 – volume: 7 start-page: 271 issue: 3 year: 2015 ident: 10.1016/j.bbadis.2024.167181_bb0130 article-title: Lentiviral vectors in cancer immunotherapy publication-title: Immunotherapy doi: 10.2217/imt.14.108 – volume: 15 start-page: 692 issue: 6 year: 2014 ident: 10.1016/j.bbadis.2024.167181_bb0050 article-title: Colorectal cancer stem cells: from the crypt to the clinic publication-title: Cell Stem Cell doi: 10.1016/j.stem.2014.11.012 |
SSID | ssj0000670 |
Score | 2.436359 |
Snippet | Cancer stem cells (CSCs) play pivotal roles in the growth, invasion, metastasis, chemo-resistance in malignant peripheral nerve sheath tumor (MPNST). The... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 167181 |
SubjectTerms | Cancer metastasis Cancer stem cells (CSCs) Decorin Malignant peripheral nerve sheath tumor (MPNST) Stemness |
Title | Decorin suppresses stemness and migration potential of malignant peripheral nerve sheath tumor through inhibiting epidermal growth factor receptor signaling |
URI | https://dx.doi.org/10.1016/j.bbadis.2024.167181 https://www.ncbi.nlm.nih.gov/pubmed/38653361 https://www.proquest.com/docview/3045119456 |
Volume | 1870 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKEYILggJleayMxDXdOnYc51gWquVVIaDS3iw7drZBu0nUzR648Ev4sczYSQWHqhKnPGQnVsb5Zpx88w0hr1WelhDlF4lnViZCpS4xpQODcH_MHVMyKzBR-POZXJyLD8tsuUfmYy4M0ioH7I-YHtB6ODMbnuasq-vZt-MC5bXAv4sgAoOaoFyokMS3fPM3GofvLNA4wdZj-lzgeFlrXI2i3ak4YhJgml3nnq4LP4MbOn1A7g_xIz2JQ3xI9nxzQO7EipI_D8jd-VjA7RH5_RaXlnVDt7su0F39lqJsM4IbNY2jm3oV7U-7tkfWEFy4regGQvMV8mMoqiAH2YE1bZAZSbcI3Re0323aSzqU-KF1c1HbGunT1GO9WYD6NV3B8h5axnI-FB6x73AH6SIGM-Afk_PTd9_ni2QoxpCU4OP6xJZlxbMyr2TloA-33pZCCQPxhVVwEpZGRebKojDOYJjkhTIZuEjHuE2lzfkTst-0jX9KqOTSAnaYTLpcOMFMyrxSorJwBZ9yMSF8tIEuB6VyLJix1iMl7YeOltNoOR0tNyHJVa8uKnXc0D4fzav_mXEanMkNPV-Ns0GDSfEPi2l8u9tq_O3MWAFB6YQcxmlyNRYsrsq5ZM_--77PyT08ikS1F2S_v9z5lxAS9XZKbh39YlNy-2T-9dMX3L7_uDibhjfhD163ERo |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwEB2VItReEBQoy6eRuIatY8dJjrBQbaHthVbam2XHzjZoN4m62UP_Cz-WmTip4FBV4hYldmJ5Rm_G8fM8gI9ZGheY5eeR51ZFMotdZAqHBhH-SDieqSSng8Jn52p-Kb8vksUOzMazMESrHLA_YHqP1sOd6TCb07aqpj-PciqvhfFd9kVg5AN4iNlASvoNJ4svf8Nx_6MFW0fUfDw_15O8rDWuoqrdsfzEFeI0vys-3ZV_9nHo-Ak8HhJI9jmM8Sns-PoAHgVJyZsD2JuNCm7P4PdXWltWNdts257v6jeM6jYTujFTO7aulsEBWNt0RBvCFzclW2NuviSCDKMyyH3dgRWriRrJNoTdV6zbrptrNmj8sKq-qmxF_GnmSXAWsX7Flri-x5ZBz4fhHPuWLogvYugI_HO4PP52MZtHgxpDVGCQ6yJbFKVIirRUpcM-wnpbyEwaTDBshjdxbZQnrshz4wzlSV5mJsEY6biwsbKpeAG7dVP7l8CUUBbBwyTKpdJJbmLus0yWFt_gYyEnIEYb6GIoVU6KGSs9ctJ-6WA5TZbTwXITiG57taFUxz3t09G8-h-X0xhN7un5YfQGjSalLRZT-2a70bTvzHmOfjiBw-Amt2MhdVUhFH_13999D3vzi7NTfXpy_uM17NOTwFp7A7vd9da_xfyos-96__8DlcMQGA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Decorin+suppresses+stemness+and+migration+potential+of+malignant+peripheral+nerve+sheath+tumor+through+inhibiting+epidermal+growth+factor+receptor+signaling&rft.jtitle=Biochimica+et+biophysica+acta.+Molecular+basis+of+disease&rft.au=Jia%2C+Xiaotian&rft.au=Chen%2C+Lin&rft.au=Yu%2C+Cong&rft.date=2024-06-01&rft.eissn=1879-260X&rft.volume=1870&rft.issue=5&rft.spage=167181&rft_id=info:doi/10.1016%2Fj.bbadis.2024.167181&rft_id=info%3Apmid%2F38653361&rft.externalDocID=38653361 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0925-4439&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0925-4439&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0925-4439&client=summon |